Fireside chat with the General Partners and some of the Technical Advisors from the SP8CEVC Team.
Fireside chat with the General Partners and some of the Technical Advisors from the SP8CEVC Team.
Sri Lanka 229-4, England yet to bat: Anderson returned to the Test arena with a flourish before Mathews’ measured 107 not out steadied the ship
Follow for the latest updates
A subgroup of the Scientific Advisory Group for Emergencies put the R at 0.8 to 1.0.
Organisers of London wedding attended by hundreds face Covid fineAbout 400 guests celebrated wedding at ultra-Orthodox Jewish school in Stamford Hill
Union Pacific Railroad's fourth quarter results could offer investors information about sectors and stocks that are on the rise.
Amazon does not have restore service for controversial social network Parler, a judge has ruled. The ruling was "not a close call", the judge said, and Amazon will not have to provide the web hosting services that it cut off in the wake of the attacks on the Capitol. US District Judge Barbara Rothstein in Seattle said she was not dismissing Parler's "substantive underlying claims" against Amazon, but said it had fallen short in demonstrating the need for an injunction forcing it back online.
The testimonies of bereavement counsellors reveals devastatingly lonely experiences of grief, unexpected feelings of loss and even some silver linings.
How Amanda Gorman became the voice of a new American eraHer recital at Joe Biden’s inauguration electrified viewers and sent the hitherto little known poet’s work to the top of the charts
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Connected Medical Devices Market (2020-2025), by Device Type, Product, End-user, Applications, Geography and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The introduction of IoT has benefitted the healthcare industry in various ways. The connected medical devices are poised to solve the challenges faced by the healthcare industry. The Healthcare industry, in recent years, has witnessed a growth of medical devices connected with each other via wireless monitoring services. The adoption of these devices is also increasing day by day owing to their reliability, effective patient monitoring and Government initiatives etc. Moreover, the penetration of mobile and internet technology and spending on R&D activities are contributing to the growth of the market. For instance, in the year 2019 more than 45 new medical devices and technologies were approved by the US FDA. As of June 2020, more than 20 connected devices are sanctioned by the FDA.However, the barriers such as high deployment cost, data security challenges, and an insufficient IoT infrastructure across the healthcare industry may hamper the market growth. The report includes a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share etc. Market DynamicsDrivers Government initiatives for promoting digital healthIncreasing focus on patient-centric delivery and patient safetyPenetration of Mobile Technologies and Internet Services Restraints High deployment cost of smart medical devices and related infrastructureIssues in data securityInsufficient IoT infrastructure across Healthcare industry Opportunities Low Doctor-to-patient ratio leading to self-operated e-Health platformsTelehealth and telemedicine services Report Highlights: A complete analysis of the market including parent industryImportant market dynamics and trendsMarket segmentationHistorical, current, and projected size of the market based on value and volumeMarket shares and strategies of key playersRecommendations to companies for strengthening their foothold in the market Key Topics Covered: 1 Report Description1.1 Study Objectives 1.2 Market Definition1.3 Currency1.4 Years Considered1.5 Language1.6 Key Shareholders2 Research Methodology2.1 Research Process2.2 Data Collection and Validation2.2.1 Secondary Research2.2.2 Primary Research2.3 Market Size Estimation2.4 Assumptions of the Study2.5 Limitations of the Study3 Executive Summary4 Market Overview4.1 Introduction 4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Trends5 Market Analysis5.1 Porter's Five Forces Analysis5.2 Impact of COVID-195.3 Ansoff Matrix Analysis6 Global Connected Medical Devices Market, By Device Type6.1 Introduction6.2 Stationary Medical Device6.3 Implantable Medical Device6.4 Wearable Medical Device6.5 Non-wearable Medical Device7 Global Connected Medical Devices Market, By Product7.1 Introduction7.2 BP Monitor7.3 Pulse Oximeter7.4 Heart Rate Monitor7.5 ECG Monitoring Device7.6 Glucose Monitor7.7 Insulin Pump7.8 Portable GPS PERS7.9 Smart Pill Dispenser7.10 Others8 Global Connected Medical Devices Market, By End-User8.1 Introduction8.2 Hospital8.3 Ambulatory Surgical Centre8.4 Specialty Clinic8.5 Home Care Settings9 Global Connected Medical Devices Market, By Application9.1 Introduction9.2 Remote Monitoring9.3 Diagnostics Services9.4 Treatment Services9.5 Fitness Device10 Global Connected Medical Devices Market, By Geography10.1 Introduction10.2 North America10.2.1 US10.2.2 Canada10.2.3 Mexico10.3 South America10.3.1 Brazil10.3.2 Argentina10.4 Europe10.4.1 UK10.4.2 France10.4.3 Germany10.4.4 Italy10.4.5 Rest of Europe10.5 Asia-Pacific10.5.1 China10.5.2 Japan10.5.3 India10.5.4 Australia10.5.5 Rest of APAC10.6 Middle East and Africa11 Competitive Landscape11.1 IGR Competitive Quadrant11.2 Market Share Analysis11.3 Competitive Scenario11.3.1 Mergers & Acquisitions11.3.2 Agreements, Collaborations, & Partnerships11.3.3 New Product Launches & Enhancements11.3.4 Investments & Fundings12 Company Profiles12.1 GE Healthcare, Inc.12.2 OMRON Corporation12.3 Medtronic Plc12.4 Philips Healthcare12.5 McKesson Corporation12.6 Fitbit, Inc.12.7 Johnson & Johnson12.8 Boston Scientific Corporation12.9 St. Jude Medical, Inc. (Abbott)12.10 AgaMatrix, Inc.12.11 Dexcom12.12 F. Hoffmann-La Roche12.13 Polar Electro12.14 IHealth Labs12.15 Aerotel Medical Systems Ltd For more information about this report visit https://www.researchandmarkets.com/r/lk191z Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Enterprise Products Partners L.P. (NYSE: EPD) announced today it will host virtual investor meetings at the U.S. Capital Advisors Midstream Corporate Access Day Monday, January 25, 2021.
Ready, an on-demand healthcare service, today announces in-home rapid COVID-19 testing with results in 15 minutes or less. The rapid test can be run from start to finish in the home, increasing the access to widespread testing outside of healthcare facilities. This testing capability not only reduces potential exposure at hospitals or testing sites, but also provides patients with fast and convenient results.
Disposable Medical Device Sensor Market Research Report by Placement of Sensors (Implantable sensors, Ingestible sensors, Invasive sensors, Strip Sensors, and Wearable sensors), by Product (Accelerometers, Biosensors, Image sensors, Pressure Sensors, and Temperature Sensors), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Disposable Medical Device Sensor Market Research Report by Placement of Sensors, by Product, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05993412/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Disposable Medical Device Sensor Market is expected to grow from USD 5,330.31 Million in 2020 to USD 8,513.46 Million by the end of 2025.2. The Global Disposable Medical Device Sensor Market is expected to grow from EUR 4,673.72 Million in 2020 to EUR 7,464.76 Million by the end of 2025.3. The Global Disposable Medical Device Sensor Market is expected to grow from GBP 4,154.94 Million in 2020 to GBP 6,636.19 Million by the end of 2025.4. The Global Disposable Medical Device Sensor Market is expected to grow from JPY 568,879.57 Million in 2020 to JPY 908,602.27 Million by the end of 2025.5. The Global Disposable Medical Device Sensor Market is expected to grow from AUD 7,740.32 Million in 2020 to AUD 12,362.68 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Disposable Medical Device Sensor to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Placement of Sensors, the Disposable Medical Device Sensor Market studied across Implantable sensors, Ingestible sensors, Invasive sensors, Strip Sensors, and Wearable sensors. Based on Product, the Disposable Medical Device Sensor Market studied across Accelerometers, Biosensors, Image sensors, Pressure Sensors, and Temperature Sensors. Based on Application, the Disposable Medical Device Sensor Market studied across Diagnostic Testing Devices, Imaging Devices, Patient Monitoring Devices, and Therapeutic Devices. The Diagnostic Testing Devices further studied across Blood Glucose Test Strips, Drug & Alcohol Test Strip Sensors, HIV Test Strip Sensors, and Pregnancy Test Strip Sensors. The Imaging Devices further studied across Capsule Endoscope Sensors and Disposable Endoscope Sensors. The Patient Monitoring Devices further studied across Bed Sensors, Cardiac Monitors, Continuous Blood Pressure Monitors, Continuous Glucose Monitoring Devices, Implantable Loop Recorders, Pulse Oximeters, and Smart Pills. The Therapeutic Devices further studied across Cardiac Catheter Sensors, Cardiac Therapy Devices, Dialysis Device Sensors, and Insulin Pump Sensors. "The Asia-Pacific is projected to witness the highest growth during the forecast period"Based on Geography, the Disposable Medical Device Sensor Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Disposable Medical Device Sensor Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Disposable Medical Device Sensor Market including Analog Devices, Inc., Curbell Medical Products, Inc., EXCEL ENGINEERING CO., Ltd., Fairmont Medical Products Pty Ltd, General Electric Company, Gentag, Inc., Honeywell International, Inc., Informa PLC, J. Brasch Co., LLC., Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, NovoSci Corp, Opto Circuits India Ltd., Sensirion AG, Smiths Group PLC, SMP Medicare Pvt. Ltd, SSI Technologies, Inc. by Amphenol Corporation, STMicroelectronics Inc., TE Connectivity Corporation, and Viomedex Limited. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.360iResearch™ FPNV Positioning Matrix:The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Disposable Medical Device Sensor Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.360iResearch™ Competitive Strategic Window:The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Disposable Medical Device Sensor Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Disposable Medical Device Sensor Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Disposable Medical Device Sensor Market?4. What is the competitive strategic window for opportunities in the Global Disposable Medical Device Sensor Market?5. What are the technology trends and regulatory frameworks in the Global Disposable Medical Device Sensor Market?6. What are the modes and strategic moves considered suitable for entering the Global Disposable Medical Device Sensor Market?Read the full report: https://www.reportlinker.com/p05993412/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
Follow for all the latest news coming from the new White House and beyond in US politics
India effectively strangled Australia with a leg-side trap to secure an epic 2-1 series victory Down Under, bowling coach Bharat Arun revealed on Friday. Humiliated in Adelaide, where they were shot out for a record innings low of 36, an injury-ravaged India drew level in Melbourne before completing a series victory for the ages by clinching the Brisbane decider. It all began with a call from head coach Ravi Shastri five months before the first test got underway in Adelaide, said Arun.
(Bloomberg) -- Spending by the global oil industry outside the U.S. is poised to rebound later this year, according to its largest hired hands, the latest sign of growing confidence in the outlook for crude prices.Schlumberger, the largest oil services company, posted better-than-expected earnings Friday and forecast an increase in overseas spending by customers in the next quarter. Earlier in the week, Halliburton Co. said markets outside North America may see double-digit growth in the second half of 2021, while Baker Hughes Co. predicted a modest recovery in Latin America, the North Sea and the Middle East.The energy sector remains wary following a calamitous 2020 that saw capital expenditures slashed as energy prices plunged. The three largest oil services companies -- who help explorers map underground reservoirs and drill their wells -- fired tens of thousands of workers and took multibillion-dollar writedowns. They’re either lessening their exposure to the shrinking U.S. shale patch and turning their attention overseas, where they see a quicker recovery.That strategy is looking like it’s paying off. Adding wind to their sails is the recovery in crude prices in the first few weeks of 2021 following OPEC+ production curbs and optimism about the recovery in global demand from Covid-19.“We believe this sets the stage for oil demand to recover to 2019 levels no later than 2023, or earlier,” Schlumberger Chief Executive Officer Olivier Le Peuch said in the statement. “Absent a setback in these macro assumptions, this will translate to meaningful activity increases both in North America and internationally.”After selling some North American assets last year and cutting almost one-quarter of the company’s workforce, Houston- and Paris-based Schlumberger now expects international markets to generate up to 80% of its revenue. It posted its worst fourth quarter revenue sales in 15 years. Still, profit for the period, excluding one-time items, was 22 cents a share, exceeding the average of analysts’ estimates in a Bloomberg survey. The stock fell 0.1% in pre-market trading at 8:46 a.m. in New York.The earnings beat is significant and the “outlook is constructive and consistent with what we have heard from HAL and BKR earlier this week,” Kurt Hallead, an analyst at RBC Capital Markets, wrote Friday in a note to investors.Schlumberger has been asking investors for more patience. It warned three months ago that it could take until late 2021 to restore profits to 2019 levels. But the company ended up achieving that goal by the end of 2020, posting an adjusted margin of 20% for earnings before interest, taxes, depreciation and amortization, the same level as the fourth quarter of 2019.“Overseas drilling activity held up better than in North America in 2020, yet it’s taking longer to recover from Covid-19-related impacts,” Scott Levine and Justin Rothhaupt, analysts at Bloomberg Intelligence, said in a report. “International upstream spending could decrease almost 20% this year, a bit weaker than anticipated at around the start of the pandemic.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The "The US Cannabidiol (CBD) Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to ResearchAndMarkets.com's offering.
Social media speculated that Casey Affleck was throwing out the cutout on his brother's behalf.
Several countries require international arrivals to provide proof of a recent negative coronavirus test.
FORM 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATIONName of person dealing (Note 1)State Street Global Advisors & AffiliatesCompany dealt inWillis Towers Watson plc.Class of relevant security to which the dealings being disclosed relate (Note 2)US$0.000304635 ordinary sharesDate of dealing21st January 2021 2. INTERESTS AND SHORT POSITIONS(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) LongShort Number(%)Number(%)(1) Relevant securities6,297,605 4.88545% (2) Derivatives (other than options)N/A (3) Options and agreements to purchase/sellN/A Total6,297,605 4.88545% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)Class of relevant security:LongShort Number(%)Number(%)(1) Relevant securitiesN/A (2) Derivatives (other than options)N/A (3) Options and agreements to purchase/sellN/A TotalN/A 3. DEALINGS (Note 4)(a) Purchases and salesPurchase/saleNumber of relevant securitiesPrice per unit (Note 5)Purchase100208.57Purchase800208.57Purchase57212.11Purchase760208.57Purchase1,005208.57Purchase340208.57Purchase8208.57Purchase36208.90Sale300211.92Sale6,800209.68Sale100208.57Sale200208.57Sale800208.57Sale900208.57Sale82208.57Sale5,928208.57Sale3,770208.57Sale100208.57 (b) Derivatives transactions (other than options transactions)Product name, e.g. CFDNature of transaction (Note 6)Number of relevant securities (Note 7)Price per unit (Note 5)N/A (c) Options transactions in respect of existing relevant securities(i) Writing, selling, purchasing or varyingProduct name, e.g. call optionWriting, selling, purchasing varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)N/A (ii) ExercisingProduct name, e.g. call optionNumber of securitiesExercise price per unit (Note 5)N/A (d) Other dealings (including transactions in respect of new securities) (Note 4)Nature of transaction (Note 8)DetailsPrice per unit (if applicable) (Note 5)N/A 4. OTHER INFORMATIONAgreements, arrangements or understandings relating to options or derivativesFull details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.N/AIs a Supplemental Form 8 attached? (Note 9)NO Date of disclosure22nd January 2021 Contact nameLionel ColacoTelephone number 020 33956098If a connected EFM, name of offeree/offeror with which connectedN/AIf a connected EFM, state nature of connection (Note 10)N/A
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth-quarter 2020 financial results on Monday, February 1, 2021 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International).